These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32393497)

  • 1. Simvastatin Improves Cardiac Function through Notch 1 Activation in BALB/c Mice with Chronic Chagas Cardiomyopathy.
    Guzmán-Rivera D; Liempi A; González-Herrera F; Fuentes-Retamal S; Carrillo I; Abarca P; Castillo C; Kemmerling U; Pesce B; Maya JD
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32393497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simvastatin Attenuates Endothelial Activation through 15-Epi-Lipoxin A4 Production in Murine Chronic Chagas Cardiomyopathy.
    González-Herrera F; Cramer A; Pimentel P; Castillo C; Liempi A; Kemmerling U; Machado FS; Maya JD
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simvastatin and Benznidazole-Mediated Prevention of Trypanosoma cruzi-Induced Endothelial Activation: Role of 15-epi-lipoxin A4 in the Action of Simvastatin.
    Campos-Estrada C; Liempi A; González-Herrera F; Lapier M; Kemmerling U; Pesce B; Ferreira J; López-Muñoz R; Maya JD
    PLoS Negl Trop Dis; 2015 May; 9(5):e0003770. PubMed ID: 25978361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin-triggered resolvin D1 reduces parasitic cardiac load by decreasing inflammation in a murine model of early chronic Chagas disease.
    Carrillo I; Rabelo RAN; Barbosa C; Rates M; Fuentes-Retamal S; González-Herrera F; Guzmán-Rivera D; Quintero H; Kemmerling U; Castillo C; Machado FS; Díaz-Araya G; Maya JD
    PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009978. PubMed ID: 34784372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations.
    Garcia S; Ramos CO; Senra JF; Vilas-Boas F; Rodrigues MM; Campos-de-Carvalho AC; Ribeiro-Dos-Santos R; Soares MB
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1521-8. PubMed ID: 15793134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term therapy with simvastatin reduces inflammatory mediators and heart inflammation during the acute phase of experimental Chagas disease.
    Silva RR; Shrestha-Bajracharya D; Almeida-Leite CM; Leite R; Bahia MT; Talvani A
    Mem Inst Oswaldo Cruz; 2012 Jun; 107(4):513-21. PubMed ID: 22666863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Chagas disease, transforming growth factor beta neutralization reduces
    Ferreira RR; de Souza EM; Vilar-Pereira G; Degrave WMS; Abreu RDS; Meuser-Batista M; Ferreira NVC; Ledbeter S; Barker RH; Bailly S; Feige JJ; Lannes-Vieira J; de Araújo-Jorge TC; Waghabi MC
    Front Cell Infect Microbiol; 2022; 12():1017040. PubMed ID: 36530434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioprotective actions of curcumin on the pathogenic NFAT/COX-2/prostaglandin E
    Hernández M; Wicz S; Corral RS
    Phytomedicine; 2016 Nov; 23(12):1392-1400. PubMed ID: 27765359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parasitaemia and parasitic load are limited targets of the aetiological treatment to control the progression of cardiac fibrosis and chronic cardiomyopathy in Trypanosoma cruzi-infected dogs.
    Caldas IS; Menezes APJ; Diniz LF; Nascimento ÁFDSD; Novaes RD; Caldas S; Bahia MT
    Acta Trop; 2019 Jan; 189():30-38. PubMed ID: 30290285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with Fenofibrate plus a low dose of Benznidazole attenuates cardiac dysfunction in experimental Chagas disease.
    Cevey ÁC; Mirkin GA; Donato M; Rada MJ; Penas FN; Gelpi RJ; Goren NB
    Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):378-387. PubMed ID: 29040909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCL3/Macrophage Inflammatory Protein-1α Is Dually Involved in Parasite Persistence and Induction of a TNF- and IFNγ-Enriched Inflammatory Milieu in
    Gibaldi D; Vilar-Pereira G; Pereira IR; Silva AA; Barrios LC; Ramos IP; Mata Dos Santos HA; Gazzinelli R; Lannes-Vieira J
    Front Immunol; 2020; 11():306. PubMed ID: 32194558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights from the use of erythropoietin in experimental Chagas disease.
    de Castro Nobre AC; Pimentel CF; do Rêgo GMS; Paludo GR; Pereira Neto GB; de Castro MB; Nitz N; Hecht M; Dallago B; Hagström L
    Int J Parasitol Drugs Drug Resist; 2022 Aug; 19():65-80. PubMed ID: 35772309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine-linked chemotherapy improves cardiac structure and function in a mouse model of chronic Chagas disease.
    Jones KM; Mangin EN; Reynolds CL; Villanueva LE; Cruz JV; Versteeg L; Keegan B; Kendricks A; Pollet J; Gusovsky F; Bottazzi ME; Hotez PJ
    Front Cell Infect Microbiol; 2023; 13():1106315. PubMed ID: 36844399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins change the cytokine profile in
    González-Herrera F; Clayton NS; Guzmán-Rivera D; Carrillo I; Castillo C; Catalán M; Anfossi R; Quintero-Pertuz H; Quilaqueo ME; Olea-Azar C; Rivera-Meza M; Kemmerling U; Ridley AJ; Vivar R; Maya JD
    Front Immunol; 2022; 13():1035589. PubMed ID: 36713380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine-linked chemotherapy with a low dose of benznidazole plus a bivalent recombinant protein vaccine prevents the development of cardiac fibrosis caused by Trypanosoma cruzi in chronically-infected BALB/c mice.
    Dzul-Huchim VM; Ramirez-Sierra MJ; Martinez-Vega PP; Rosado-Vallado ME; Arana-Argaez VE; Ortega-Lopez J; Gusovsky F; Dumonteil E; Cruz-Chan JV; Hotez P; Bottazzi ME; Villanueva-Lizama LE
    PLoS Negl Trop Dis; 2022 Sep; 16(9):e0010258. PubMed ID: 36095001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-aminopyridyl-based lead compounds targeting CYP51 prevent spontaneous parasite relapse in a chronic model and improve cardiac pathology in an acute model of Trypanosoma cruzi infection.
    Calvet CM; Choi JY; Thomas D; Suzuki B; Hirata K; Lostracco-Johnson S; de Mesquita LB; Nogueira A; Meuser-Batista M; Silva TA; Siqueira-Neto JL; Roush WR; de Souza Pereira MC; McKerrow JH; Podust LM
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006132. PubMed ID: 29281643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Efficacy of a Subunit Vaccine in Controlling Chronic Trypanosoma cruzi Infection and Chagas Disease Is Enhanced by Glutathione Peroxidase Over-Expression.
    Gupta S; Smith C; Auclair S; Delgadillo Ade J; Garg NJ
    PLoS One; 2015; 10(6):e0130562. PubMed ID: 26075398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low doses of simvastatin therapy ameliorate cardiac inflammatory remodeling in Trypanosoma cruzi-infected dogs.
    Melo L; Caldas IS; Azevedo MA; Gonçalves KR; da Silva do Nascimento AF; Figueiredo VP; de Figueiredo Diniz L; de Lima WG; Torres RM; Bahia MT; Talvani A
    Am J Trop Med Hyg; 2011 Feb; 84(2):325-31. PubMed ID: 21292909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination Therapy Using Benznidazole and Aspirin during the Acute Phase of Experimental Chagas Disease Prevents Cardiovascular Dysfunction and Decreases Typical Cardiac Lesions in the Chronic Phase.
    Pereira RS; Malvezi AD; Lovo-Martins MI; Lucchetti BFC; Santos JP; Tavares ER; Verri WA; de Almeida Araújo EJ; Yamauchi LM; Yamada-Ogatta SF; Martins-Pinge MC; Pinge-Filho P
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32366719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the Effectiveness of Curative Benznidazole Treatment in Preventing Chronic Cardiac Pathology in Experimental Models of Chagas Disease.
    Francisco AF; Jayawardhana S; Taylor MC; Lewis MD; Kelly JM
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30082291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.